GeoVax Labs Warrants
GOVXW
GOVXW was delisted on the 26th of September, 2025.
5 hedge funds and large institutions have $2.73K invested in GeoVax Labs Warrants in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
400% more funds holding
Funds holding: 1 → 5 (+4)
62% less capital invested
Capital invested by funds: $7.13K → $2.73K (-$4.4K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.3K |
| 2 |
MG
Marex Group
London,
|
+$956 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$102 |
| 4 |
CS
Clear Street
New York
|
+$19 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$172 |
GOVXW Hedge Fund Activity: Q4 2023 in Review
5 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs Warrants (GOVXW) for Q4 2023, worth a combined $2.73K — down 62% from $7.13K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GOVXW positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.3K. The largest seller was CVI Holdings, cutting an estimated $172.
- 5 institutional investors held GeoVax Labs Warrants (GOVXW) as of Q4 2023, up from 1 in Q3 2023.
- Funds reported $2.73K of GeoVax Labs Warrants stock for Q4 2023, down 62% quarter-over-quarter.
- 4 funds opened new GeoVax Labs Warrants positions in Q4 2023 and 0 closed out, a net change of +4 holders.
- The largest GeoVax Labs Warrants buyer in Q4 2023 was Susquehanna International Group, an estimated $1.3K added.
- The largest GeoVax Labs Warrants seller in Q4 2023 was CVI Holdings, an estimated $172 sold.
Based on aggregated 13F filings for Q4 2023.